Matches in Wikidata for { <http://www.wikidata.org/entity/Q92733582> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q92733582 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q92733582 description "scientific article published on 17 August 2019" @default.
- Q92733582 description "wetenschappelijk artikel" @default.
- Q92733582 description "наукова стаття, опублікована 17 серпня 2019" @default.
- Q92733582 name "Safety and efficacy of reduced dose and margins to involved lymph node metastases in locally advanced NSCLC patients" @default.
- Q92733582 name "Safety and efficacy of reduced dose and margins to involved lymph node metastases in locally advanced NSCLC patients" @default.
- Q92733582 type Item @default.
- Q92733582 label "Safety and efficacy of reduced dose and margins to involved lymph node metastases in locally advanced NSCLC patients" @default.
- Q92733582 label "Safety and efficacy of reduced dose and margins to involved lymph node metastases in locally advanced NSCLC patients" @default.
- Q92733582 prefLabel "Safety and efficacy of reduced dose and margins to involved lymph node metastases in locally advanced NSCLC patients" @default.
- Q92733582 prefLabel "Safety and efficacy of reduced dose and margins to involved lymph node metastases in locally advanced NSCLC patients" @default.
- Q92733582 P1433 Q92733582-01B68A88-678B-4C95-80C3-E11CE77DE768 @default.
- Q92733582 P1476 Q92733582-EFC23310-DC0E-4616-8257-08E5F3339578 @default.
- Q92733582 P2093 Q92733582-0E7BDC9F-34D2-4D40-B3C1-1D215DCC35D1 @default.
- Q92733582 P2093 Q92733582-1A1B94A3-5B91-4029-BE01-31C40DC09100 @default.
- Q92733582 P2093 Q92733582-2CE185AF-1281-4A2D-A89C-3F5BEF5E4FB5 @default.
- Q92733582 P2093 Q92733582-2F60DB93-35A3-44B2-99E2-5812F73473AD @default.
- Q92733582 P2093 Q92733582-4A8BAB0A-4FC4-47AB-80B1-0D994960AFC0 @default.
- Q92733582 P2093 Q92733582-5F88075E-33B3-4969-916B-2BDC45EC6ACE @default.
- Q92733582 P2093 Q92733582-C571C6ED-F98F-4CD0-8F51-827808933D60 @default.
- Q92733582 P304 Q92733582-1ACB3361-BEB7-444F-9E1F-3D94B332E8E9 @default.
- Q92733582 P31 Q92733582-2DFEC1C1-A880-4BF4-8747-2F42FCC3AB93 @default.
- Q92733582 P356 Q92733582-9D6697DA-8D83-4FB3-B4A6-855D7861A137 @default.
- Q92733582 P478 Q92733582-AC4A94EA-E7E6-44C0-88CC-894D30D8A604 @default.
- Q92733582 P50 Q92733582-307291B2-BDCD-4CBC-9E03-64AB99C1A053 @default.
- Q92733582 P577 Q92733582-47792C66-4DAD-4D28-9401-71ACAB405557 @default.
- Q92733582 P698 Q92733582-6B8D970C-F244-42CA-956F-2E51D3F24DB7 @default.
- Q92733582 P921 Q92733582-D6408F10-2228-41A5-A041-49C7F7F4698B @default.
- Q92733582 P356 J.RADONC.2019.07.028 @default.
- Q92733582 P698 31431389 @default.
- Q92733582 P1433 Q14251029 @default.
- Q92733582 P1476 "Safety and efficacy of reduced dose and margins to involved lymph node metastases in locally advanced NSCLC patients" @default.
- Q92733582 P2093 "Adrianus J de Langen" @default.
- Q92733582 P2093 "Barbara Stam" @default.
- Q92733582 P2093 "Iris Walraven" @default.
- Q92733582 P2093 "Joost Knegjens" @default.
- Q92733582 P2093 "José S A Belderbos" @default.
- Q92733582 P2093 "Judi N A van Diessen" @default.
- Q92733582 P2093 "Margriet Kwint" @default.
- Q92733582 P304 "66-72" @default.
- Q92733582 P31 Q13442814 @default.
- Q92733582 P356 "10.1016/J.RADONC.2019.07.028" @default.
- Q92733582 P478 "143" @default.
- Q92733582 P50 Q86720794 @default.
- Q92733582 P577 "2019-08-17T00:00:00Z" @default.
- Q92733582 P698 "31431389" @default.
- Q92733582 P921 Q3658562 @default.